{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:02:01Z","timestamp":1791925321496,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jsps.2021.12.021","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T07:21:59Z","timestamp":1640935319000},"page":"108-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Successful treatment of linezolid-induced severe lactic acidosis with continuous venovenous hemodiafiltration: A case report"],"prefix":"10.1007","volume":"30","author":[{"given":"Naiju","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2021.12.021_b0005","first-page":"87","article-title":"Clinical update on linezolid in the treatment of Gram-positive bacterial infections","volume":"5","author":"Ager","year":"2012","journal-title":"Infect Drug Resist."},{"key":"10.1016\/j.jsps.2021.12.021_b0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12941-016-0156-y","article-title":"Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis","volume":"15","author":"Agyeman","year":"2016","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"1","key":"10.1016\/j.jsps.2021.12.021_b0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM200301023480123","article-title":"Linezolid-induced lactic acidosis","volume":"348","author":"Apodaca","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2021.12.021_b0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.diabres.2017.03.012","article-title":"Angiogenic effects of low-intensity cathodal direct current on ischemic diabetic foot ulcers: A randomized controlled trial","volume":"127","author":"Asadi","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"8","key":"10.1016\/j.jsps.2021.12.021_b0025","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1097\/CCM.0000000000001002","article-title":"Extracorporeal Treatment for Metformin Poisoning: Systematic Review and Recommendations From the Extracorporeal Treatments in Poisoning Workgroup","volume":"43","author":"Calello","year":"2015","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.jsps.2021.12.021_b0030","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijantimicag.2016.08.023","article-title":"Therapeutic drug management of linezolid: a missed opportunity for clinicians?","volume":"48","author":"Cattaneo","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6","key":"10.1016\/j.jsps.2021.12.021_b0035","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijantimicag.2013.02.020","article-title":"Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections","volume":"41","author":"Cattaneo","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7","key":"10.1016\/j.jsps.2021.12.021_b0040","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.00388-13","article-title":"Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis?","volume":"57","author":"Chang","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.jsps.2021.12.021_b0045","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jiac.2018.02.002","article-title":"Early linezolid-associated lactic acidosis in a patient with Child's class C liver cirrhosis and end stage renal disease","volume":"24","author":"Cheng","year":"2018","journal-title":"J Infect Chemother."},{"key":"10.1016\/j.jsps.2021.12.021_b0050","series-title":"Lactic Acidosis","author":"Christopher","year":"2018"},{"issue":"24","key":"10.1016\/j.jsps.2021.12.021_b0055","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1074\/jbc.M302109200","article-title":"Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics","volume":"278","author":"Colca","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.jsps.2021.12.021_b0060","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.jsps.2021.12.021_b0065","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1128\/AAC.02856-14","article-title":"Linezolid-induced lactic acidosis in two liver transplant patients with the mitochondrial DNA A2706G polymorphism","volume":"58","author":"Del Pozo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.jsps.2021.12.021_b0070","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jsps.2021.12.021_b0075","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/SHK.0000000000000667","article-title":"Blood Lactate Levels Cutoff and Mortality Prediction in Sepsis-Time for a Reappraisal? a Retrospective Cohort Study","volume":"46","author":"Filho","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.jsps.2021.12.021_b0080","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jac\/dki148","article-title":"Linezolid for the treatment of multidrug-resistant tuberculosis","volume":"56","author":"Fort\u00fan","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl 2","key":"10.1016\/j.jsps.2021.12.021_b0085","first-page":"ii45-53","article-title":"Safety and tolerability of linezolid","volume":"51","author":"French","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jsps.2021.12.021_b0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijid.2014.12.009","article-title":"Incidence and risk factors of linezolid-induced lactic acidosis","volume":"31","author":"Im","year":"2015","journal-title":"Int J Infect Dis."},{"issue":"2","key":"10.1016\/j.jsps.2021.12.021_b0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jac\/dkp171","article-title":"Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis","volume":"64","author":"Koh","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"24","key":"10.1016\/j.jsps.2021.12.021_b0100","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic acidosis","volume":"371","author":"Ingelfinger","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.jsps.2021.12.021_b0105","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJMoa1201964","article-title":"Linezolid for treatment of chronic extensively drug-resistant tuberculosis","volume":"367","author":"Lee","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2021.12.021_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3868051","article-title":"Severe Metformin Poisoning Successfully Treated with Simultaneous Venovenous Hemofiltration and Prolonged Intermittent Hemodialysis","volume":"2018","author":"Leonaviciute","year":"2018","journal-title":"Case Rep Crit Care."},{"key":"10.1016\/j.jsps.2021.12.021_b0115","article-title":"Incidence and Associated Risk Factors for Lactic Acidosis Induced by Linezolid Therapy in a Case-Control Study in Patients Older Than 85 Years","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med (Lausanne)."},{"issue":"3","key":"10.1016\/j.jsps.2021.12.021_b0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijantimicag.2014.05.010","article-title":"Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients","volume":"44","author":"Matsumoto","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"9","key":"10.1016\/j.jsps.2021.12.021_b0125","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1080\/14656566.2016.1182154","article-title":"Risk factors associated with high linezolid trough plasma concentrations","volume":"17","author":"Morata","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.jsps.2021.12.021_b0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.jsps.2021.12.021_b0135","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/jac\/dkt133","article-title":"High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia","volume":"68","author":"Nukui","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.jsps.2021.12.021_b0140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/tcrm.1.2.141.62908","article-title":"Renal replacement therapy in the intensive care unit","volume":"1","author":"Pannu","year":"2005","journal-title":"Ther. Clin. Risk Manag."},{"issue":"4","key":"10.1016\/j.jsps.2021.12.021_b0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bcpt.12797","article-title":"A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?","volume":"121","author":"Pea","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.jsps.2021.12.021_b0150","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1086\/499533","article-title":"Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient","volume":"42","author":"Pea","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jsps.2021.12.021_b0155","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/jac\/dks153","article-title":"Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients","volume":"67","author":"Pea","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jsps.2021.12.021_b0160","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s13054-014-0525-x","article-title":"Therapeutic drug monitoring: linezolid too?","volume":"18","author":"Richards","year":"2014","journal-title":"Crit. Care"},{"issue":"7","key":"10.1016\/j.jsps.2021.12.021_b0165","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14740338.2017.1335305","article-title":"Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes","volume":"16","author":"Santini","year":"2017","journal-title":"Expert Opin Drug Saf."},{"issue":"5","key":"10.1016\/j.jsps.2021.12.021_b0170","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/AAC.01185-10","article-title":"Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients","volume":"55","author":"Sasaki","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.jsps.2021.12.021_b0175","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ebiom.2015.09.051","article-title":"Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis","volume":"2","author":"Song","year":"2015","journal-title":"EBioMedicine."},{"issue":"8","key":"10.1016\/j.jsps.2021.12.021_b0180","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00751-17","article-title":"Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis","volume":"61","author":"Srivastava","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.jsps.2021.12.021_b0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1183\/09031936.00035114","article-title":"Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China","volume":"45","author":"Tang","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jsps.2021.12.021_b0190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/INF.0000000000002067","article-title":"Population Pharmacokinetics of Intravenous Linezolid in Premature Infants","volume":"38","author":"Thibault","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"4","key":"10.1016\/j.jsps.2021.12.021_b0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nrneph.2010.20","article-title":"A case of lactic acidosis induced by linezolid","volume":"6","author":"Velez","year":"2010","journal-title":"Nat. Rev. Nephrol."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S131901642100270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S131901642100270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:26:39Z","timestamp":1736184399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S131901642100270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S131901642100270X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2021.12.021","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of linezolid-induced severe lactic acidosis with continuous venovenous hemodiafiltration: A case report","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2021.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}